Zobrazeno 1 - 10
of 579
pro vyhledávání: '"Demirkan F."'
Publikováno v:
In Revista Española de Medicina Nuclear e Imagen Molecular July-August 2019 38(4):212-217
Autor:
Marchesi F, Salmanton-García J, Emarah Z, Piukovics K, Nucci M, López-García A, Ráčil Z, Farina F, Popova M, Zompi S, Audisio E, Ledoux MP, Verga L, Weinbergerová B, Szotkovski T, Da Silva MG, Fracchiolla N, De Jonge N, Collins G, Marchetti M, Magliano G, García-Vidal C, Biernat MM, Van Doesum J, Machado M, Demirkan F, Al- Khabori M, Žák P, Víšek B, Stoma I, Méndez GA, Maertens J, Khanna N, Espigado I, Dragonetti G, Fianchi L, Del Principe MI, Cabirta A, Ormazabal- Vélez I, Jaksic O, Buquicchio C, Bonuomo V, Batinić J, Omrani AS, Lamure S, Finizio O, Fernández N, Falces-Romero I, Blennow O, Bergantim R, Ali N, Win S, Van Praet J, Tisi MC, Shirinova A, Schönlein M, Prattes J, Piedimonte M, Petzer V, Navrátil M, Kulasekararaj A, Jindra P, Sramek J, Glenthøj A, Fazzi R, De Ramón-Sánchez C, Cattaneo C, Calbacho M, Bahr NC, El-Ashwah S, Cordoba R, Hanakova M, Zambrotta G, Sciumè M, Booth S, Rodrigues RN, Sacchi MV, García-Poutón N, Martín- González JA, Khostelidi S, Gräfe S, Rahimli L, Ammatuna E, Busca A, Corradini P, Hoenigl M, Klimko N, Koehler P, Pagliuca A, Passamonti F, Cornely OA, Pagano L, EPICOVIDEHA working group.
Patients with acute myeloid leukemia (AML) are at high risk of dying from coronavirus disease 2019 (COVID-19). The optimal management of AML patients with COVID-19 has not been established. Our multicenter study included 388 adult AML patients diagno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::8e7faa67973d65771bf59e85d1b530ba
https://doi.org/10.3324/haematol.2022.280847.
https://doi.org/10.3324/haematol.2022.280847.
Autor:
Pagano, Livio, Salmanton-Garcia, J., Marchesi, F., Blennow, O., Gomes da Silva, M., Glenthoj, A., van Doesum, J., Bilgin, Y. M., Lopez-Garcia, A., Itri, F., Nunes Rodrigues, R., Weinbergerova, B., Farina, F., Dragonetti, Giulia, Berg Venemyr, C., van Praet, J., Jaksic, O., Valkovic, T., Falces-Romero, I., Martin-Perez, S., Jimenez, M., Davila-Valls, J., Schonlein, M., Ammatuna, E., Meers, S., Delia, M., Stojanoski, Z., Nordlander, A., Lahmer, T., Imre Pinczes, L., Buquicchio, C., Piukovics, K., Ormazabal-Velez, I., Fracchiolla, N., Samarkos, M., Mendez, G. -A., Hernandez-Rivas, J. -A., Espigado, I., Cernan, M., Petzer, V., Lamure, S., di Blasi, R., Marques de Almedia, J., Dargenio, M., Biernat, M. M., Sciume, M., de Ramon, C., de Jonge, N., Batinic, J., Aujayeb, A., Marchetti, M., Fouquet, G., Fernandez, N., Zambrotta, G., Sacchi, M. V., Guidetti, A., Demirkan, F., Prezioso, L., Racil, Z., Nucci, M., Mladenovic, M., Lievin, R., Hanakova, M., Grafe, S., Sili, U., Machado, M., Cattaneo, C., Adzic-Vukicevic, T., Verga, L., Labrador, J., Rahimli, L., Bonanni, Matteo, Passamonti, F., Pagliuca, A., Corradini, P., Hoenigl, M., Koehler, P., Busca, A., Cornely, O. A., Serrano, L., Ribera-Santa Susana, J. -M., Meletiadis, J., Tsirigotis, P., Coppola, N., Mikulska, M., Erben, N., Besson, C., Merelli, M., Gonzalez-Lopez, T. -J., Loureiro-Amigo, J., Garcia-Vidal, C., Kort, E. D., Cuccaro, A., Zompi, S., Reizine, F., Finizio, O., Dulery, R., Calbacho, M., Abu-Zeinah, G., Malak, S., Zdziarski, P., Varrichio, G., Tragiannidis, A., Plantefeve, G., Duarte, R., Danion, F., Tisi, M. C., Sakellari, I., Karthaus, M., Groh, A., Fung, M., Emarah, Z., Coronel-Ayala, O. -F., Ann Chai, L. Y., Brehon, M., Bonuomo, V., Wolf, D., Wittig, J., Vehreschild, M., Papa, M. V., Neuhann, J., Jimenez-Lorenzo, M. -J., Grothe, J., Gavriilaki, E., Garcia-Sanz, R., Garcia-Pouton, N., El-Ashwah, S. S., Eggerer, M., Cordoba, R., Colak, G. M., Arellano, E.
Publikováno v:
Blood, 140(26), 2773-2787. American Society of Hematology
Blood
Volume 140
Issue 26
Blood, vol 140, iss 26
EPICOVIDEHA Survey members 2022, ' Breakthrough COVID-19 in vaccinated patients with hematologic malignancies : results from the EPICOVIDEHA survey ', Blood, vol. 140, no. 26, pp. 2773-2787 . https://doi.org/10.1182/blood.2022017257
Blood, 140(26). AMER SOC HEMATOLOGY
Pagano, L, Salmanton-garcía, J, Marchesi, F, Blennow, O, Gomes Da Silva, M, Glenthøj, A, Van Doesum, J A, Bilgin, Y M, Lopez-garcia, A, Itri, F, Nunes Rodrigues, R, Weinbergerová, B, Farina, F, Dragonetti, G, Berg Venemyr, C, Van Praet, J, Jaksic, O, Valkovic, T, Falces-romero, I, Martin-perez, S, Jiménez, M, Davila-valls, J, Schonlein, M, Ammatuna, E, Meers, S, Delia, M, Stojanoski, Z, Nordlander, A, Lahmer, T, Pinczés, L I, Buquicchio, C, Piukovics, K, Ormazabal-velez, I, Fracchiolla, N S, Samarkos, M, Mendez, G, Hernández-rivas, J, Espigado, I, Cernan, M, Petzer, V, Lamure, S, Di Blasi, R, Marques De Almeida, J, Dargenio, M, Biernat, M M, Sciumè, M, De Ramón, C, De Jonge, N A, Batinic, J, Aujayeb, A, Marchetti, M, Fouquet, G, Fernández Escalada, N, Zambrotta, G P M, Sacchi, M V, Guidetti, A, Demirken, F, Prezioso, L, Racil, Z, Nucci, M, Mladenovic, M, Lievin, R, Hanakova, M, Grafe, S K, Sili, U, Machado, M, Cattaneo, C, Adzic-vukicevic, T, Verga, L, Labrador, J, Rahimli, L, Bonanni, M, Passamonti, F, Pagliuca, A, Corradini, P, Hoenigl, M, Koehler, P, Busca, A & Cornely, O A 2022, ' Breakthrough COVID-19 in vaccinated patients with hematologic malignancies : results from EPICOVIDEHA survey ', Blood, pp. 2773–2787 . https://doi.org/10.1182/blood.2022017257
Blood
Volume 140
Issue 26
Blood, vol 140, iss 26
EPICOVIDEHA Survey members 2022, ' Breakthrough COVID-19 in vaccinated patients with hematologic malignancies : results from the EPICOVIDEHA survey ', Blood, vol. 140, no. 26, pp. 2773-2787 . https://doi.org/10.1182/blood.2022017257
Blood, 140(26). AMER SOC HEMATOLOGY
Pagano, L, Salmanton-garcía, J, Marchesi, F, Blennow, O, Gomes Da Silva, M, Glenthøj, A, Van Doesum, J A, Bilgin, Y M, Lopez-garcia, A, Itri, F, Nunes Rodrigues, R, Weinbergerová, B, Farina, F, Dragonetti, G, Berg Venemyr, C, Van Praet, J, Jaksic, O, Valkovic, T, Falces-romero, I, Martin-perez, S, Jiménez, M, Davila-valls, J, Schonlein, M, Ammatuna, E, Meers, S, Delia, M, Stojanoski, Z, Nordlander, A, Lahmer, T, Pinczés, L I, Buquicchio, C, Piukovics, K, Ormazabal-velez, I, Fracchiolla, N S, Samarkos, M, Mendez, G, Hernández-rivas, J, Espigado, I, Cernan, M, Petzer, V, Lamure, S, Di Blasi, R, Marques De Almeida, J, Dargenio, M, Biernat, M M, Sciumè, M, De Ramón, C, De Jonge, N A, Batinic, J, Aujayeb, A, Marchetti, M, Fouquet, G, Fernández Escalada, N, Zambrotta, G P M, Sacchi, M V, Guidetti, A, Demirken, F, Prezioso, L, Racil, Z, Nucci, M, Mladenovic, M, Lievin, R, Hanakova, M, Grafe, S K, Sili, U, Machado, M, Cattaneo, C, Adzic-vukicevic, T, Verga, L, Labrador, J, Rahimli, L, Bonanni, M, Passamonti, F, Pagliuca, A, Corradini, P, Hoenigl, M, Koehler, P, Busca, A & Cornely, O A 2022, ' Breakthrough COVID-19 in vaccinated patients with hematologic malignancies : results from EPICOVIDEHA survey ', Blood, pp. 2773–2787 . https://doi.org/10.1182/blood.2022017257
Limited data are available on breakthrough COVID-19 in patients with hematologic malignancy (HM) after anti–severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. Adult patients with HM, ≥1 dose of anti-SARS-CoV-2 vaccine, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46d068f242283040ec3d5be079ebd89c
https://research.vumc.nl/en/publications/c62a76e2-fca2-45ed-a697-f1017ce3b6ec
https://research.vumc.nl/en/publications/c62a76e2-fca2-45ed-a697-f1017ce3b6ec
Background: The outcome of patients with simultaneous diagnosis of haematological malignancies (HM) and COVID-19 is unknown and there are no specific treatment guidelines. Methods: We describe the clinical features and outcome of a cohort of 450 pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::fc53ba7f9e6a0be9d2f12aca501d215e
https://doi.org/10.3390/cancers14225530.
https://doi.org/10.3390/cancers14225530.
No obstract available
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::14f00f8530831f8f39bc1735cb5ed637
https://doi.org/10.1182/bloodadvances.2022007357.
https://doi.org/10.1182/bloodadvances.2022007357.
Limited data are available on breakthrough COVID- 19 in patients with hematologic malignancy (HM) after anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. Adult patients with HM, ≥1 dose of anti-SARS-CoV-2 vaccine, and b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::17630ac5513ee7c883f0a157437b0e16
https://www.bib.irb.hr/1253907
https://www.bib.irb.hr/1253907
Autor:
Özkan, Ö., Demirkan, F., Dinçkan, A., Hadimioglu, N., Tuzuner, S., Suleymanlar, G., Gunseren, F.
Publikováno v:
In Transplantation Proceedings 2011 43(9):3557-3560
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.